25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Medprin Regenerative Medical Technologies Co. Ltd.
Buy, Hold or Sell?

Let's analyze Medprin together

I guess you are interested in Medprin Regenerative Medical Technologies Co. Ltd.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Medprin Regenerative Medical Technologies Co. Ltd.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Medprin Regenerative Medical Technologies Co. Ltd.

I send you an email if I find something interesting about Medprin Regenerative Medical Technologies Co. Ltd..

1. Quick Overview

1.1. Quick analysis of Medprin (30 sec.)










1.2. What can you expect buying and holding a share of Medprin? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
77.8%

What is your share worth?

Current worth
¥9.58
Expected worth in 1 year
¥10.13
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.96
Return On Investment
2.0%

For what price can you sell your share?

Current Price per Share
¥48.76
Expected price per share
¥43.00 - ¥57.32
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Medprin (5 min.)




Live pricePrice per Share (EOD)
¥48.76

2.2. Growth of Medprin (5 min.)




Is Medprin growing?

Current yearPrevious yearGrowGrow %
How rich?$88.1m$83.2m$4.2m4.9%

How much money is Medprin making?

Current yearPrevious yearGrowGrow %
Making money$2.1m$957k$1.1m54.9%
Net Profit Margin23.4%15.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Medprin (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Medprin?

Welcome investor! Medprin's management wants to use your money to grow the business. In return you get a share of Medprin.

First you should know what it really means to hold a share of Medprin. And how you can make/lose money.

Speculation

The Price per Share of Medprin is ¥48.76. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medprin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medprin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥9.58. Based on the TTM, the Book Value Change Per Share is ¥0.14 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medprin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.040.1%0.030.1%0.010.0%0.020.0%0.020.0%
Usd Book Value Change Per Share-0.010.0%0.020.0%0.010.0%0.150.3%0.150.3%
Usd Dividend Per Share0.050.1%0.010.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.040.1%0.030.1%0.020.0%0.160.3%0.160.3%
Usd Price Per Share5.41-5.33-6.00-5.70-5.70-
Price to Earnings Ratio37.28-42.05-117.51-74.94-74.94-
Price-to-Total Gains Ratio138.96-173.68-449.61-270.15-270.15-
Price to Book Ratio4.08-4.05-4.80-4.50-4.50-
Price-to-Total Gains Ratio138.96-173.68-449.61-270.15-270.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.738632
Number of shares148
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.15
Usd Total Gains Per Share0.030.16
Gains per Quarter (148 shares)4.9123.22
Gains per Year (148 shares)19.6692.90
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
19111068783
217223012174176
326335017261269
434457023348362
543569029436455
6516711035523548
7607813040610641
8688915046697734
97710017052784827
108511119058871920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%7.02.00.077.8%7.02.00.077.8%7.02.00.077.8%7.02.00.077.8%
Dividend per Share4.00.00.0100.0%7.00.02.077.8%7.00.02.077.8%7.00.02.077.8%7.00.02.077.8%
Total Gains per Share4.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Medprin Regenerative Medical Technologies Co. Ltd. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1060.136-178%0.056-290%1.065-110%1.065-110%
Book Value Per Share--9.5849.519+1%9.056+6%9.208+4%9.208+4%
Current Ratio--6.5385.092+28%4.689+39%6.171+6%6.171+6%
Debt To Asset Ratio--0.1020.163-38%0.184-45%0.180-43%0.180-43%
Debt To Equity Ratio--0.1130.197-42%0.227-50%0.221-49%0.221-49%
Dividend Per Share--0.3880.104+272%0.073+431%0.071+449%0.071+449%
Eps--0.2620.231+14%0.104+152%0.173+52%0.173+52%
Free Cash Flow Per Share--0.0970.221-56%0.063+55%0.020+378%0.020+378%
Free Cash Flow To Equity Per Share--0.0970.221-56%0.063+55%0.020+378%0.020+378%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap3243485944.000+20%2601573734.0002565154362.500+1%2890046198.667-10%2745920832.000-5%2745920832.000-5%
Net Profit Margin--0.2690.234+15%0.158+70%0.205+31%0.205+31%
Operating Margin----0%-0%-0%-0%
Operating Ratio--0.9450.923+2%1.027-8%0.964-2%0.964-2%
Pb Ratio5.088+20%4.0814.053+1%4.797-15%4.496-9%4.496-9%
Pe Ratio46.479+20%37.28142.050-11%117.506-68%74.943-50%74.943-50%
Price Per Share48.760+20%39.11038.563+1%43.447-10%41.280-5%41.280-5%
Price To Free Cash Flow Ratio125.544+20%100.69865.233+54%22.078+356%29.105+246%29.105+246%
Price To Total Gains Ratio173.242+20%138.956173.681-20%449.615-69%270.147-49%270.147-49%
Quick Ratio--3.6363.378+8%3.703-2%4.776-24%4.776-24%
Return On Assets--0.0250.020+21%0.009+164%0.015+60%0.015+60%
Return On Equity--0.0270.024+13%0.011+138%0.019+47%0.019+47%
Total Gains Per Share--0.2810.240+17%0.129+119%1.135-75%1.135-75%
Usd Book Value--88101933.35087504980.998+1%83252598.707+6%84653119.824+4%84653119.824+4%
Usd Book Value Change Per Share---0.0150.019-178%0.008-290%0.147-110%0.147-110%
Usd Book Value Per Share--1.3241.315+1%1.252+6%1.273+4%1.273+4%
Usd Dividend Per Share--0.0540.014+272%0.010+431%0.010+449%0.010+449%
Usd Eps--0.0360.032+14%0.014+152%0.024+52%0.024+52%
Usd Free Cash Flow--892614.7062027829.492-56%576973.084+55%186795.475+378%186795.475+378%
Usd Free Cash Flow Per Share--0.0130.030-56%0.009+55%0.003+378%0.003+378%
Usd Free Cash Flow To Equity Per Share--0.0130.030-56%0.009+55%0.003+378%0.003+378%
Usd Market Cap448249757.461+20%359537490.039354504332.898+1%399404384.656-10%379486258.982-5%379486258.982-5%
Usd Price Per Share6.739+20%5.4055.329+1%6.004-10%5.705-5%5.705-5%
Usd Profit--2411026.8142120556.077+14%957019.891+152%1587637.889+52%1587637.889+52%
Usd Revenue--8960987.6969231793.942-3%5986017.736+50%7557518.980+19%7557518.980+19%
Usd Total Gains Per Share--0.0390.033+17%0.018+119%0.157-75%0.157-75%
 EOD+4 -4MRQTTM+21 -13YOY+26 -85Y+24 -1010Y+24 -10

3.3 Fundamental Score

Let's check the fundamental score of Medprin Regenerative Medical Technologies Co. Ltd. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1546.479
Price to Book Ratio (EOD)Between0-15.088
Net Profit Margin (MRQ)Greater than00.269
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.636
Current Ratio (MRQ)Greater than16.538
Debt to Asset Ratio (MRQ)Less than10.102
Debt to Equity Ratio (MRQ)Less than10.113
Return on Equity (MRQ)Greater than0.150.027
Return on Assets (MRQ)Greater than0.050.025
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Medprin Regenerative Medical Technologies Co. Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.883
Ma 20Greater thanMa 5049.700
Ma 50Greater thanMa 10045.418
Ma 100Greater thanMa 20042.359
OpenGreater thanClose48.990
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Medprin Regenerative Medical Technologies Co. Ltd.

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers dura membrane patches, regenerated oxidized cellulose, and craniomaxillofacial repair systems. It also offers ReDura, NeoDura, Recranio, and StypCel for neurosurgery, and 3D bioprinting applications serving patients internationally. Medprin Regenerative Medical Technologies Co., Ltd. was founded in 2008 and is based in Guangzhou, China.

Fundamental data was last updated by Penke on 2024-11-12 08:31:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Medprin earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Medprin to the Medical Devices industry mean.
  • A Net Profit Margin of 26.9% means that ¥0.27 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The MRQ is 26.9%. The company is making a huge profit. +2
  • The TTM is 23.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ26.9%TTM23.4%+3.5%
TTM23.4%YOY15.8%+7.6%
TTM23.4%5Y20.5%+2.9%
5Y20.5%10Y20.5%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ26.9%-5.5%+32.4%
TTM23.4%-15.3%+38.7%
YOY15.8%-15.2%+31.0%
5Y20.5%-18.1%+38.6%
10Y20.5%-23.4%+43.9%
4.3.1.2. Return on Assets

Shows how efficient Medprin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medprin to the Medical Devices industry mean.
  • 2.5% Return on Assets means that Medprin generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The MRQ is 2.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.5%TTM2.0%+0.4%
TTM2.0%YOY0.9%+1.1%
TTM2.0%5Y1.5%+0.5%
5Y1.5%10Y1.5%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5%-2.1%+4.6%
TTM2.0%-3.2%+5.2%
YOY0.9%-4.0%+4.9%
5Y1.5%-3.0%+4.5%
10Y1.5%-4.1%+5.6%
4.3.1.3. Return on Equity

Shows how efficient Medprin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medprin to the Medical Devices industry mean.
  • 2.7% Return on Equity means Medprin generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The MRQ is 2.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.4%+0.3%
TTM2.4%YOY1.1%+1.3%
TTM2.4%5Y1.9%+0.6%
5Y1.9%10Y1.9%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7%-2.2%+4.9%
TTM2.4%-3.8%+6.2%
YOY1.1%-4.2%+5.3%
5Y1.9%-4.4%+6.3%
10Y1.9%-5.7%+7.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Medprin Regenerative Medical Technologies Co. Ltd..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Medprin is operating .

  • Measures how much profit Medprin makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medprin to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.2%+11.2%
TTM--17.2%+17.2%
YOY--13.0%+13.0%
5Y--17.4%+17.4%
10Y--19.8%+19.8%
4.3.2.2. Operating Ratio

Measures how efficient Medprin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.94 means that the operating costs are ¥0.94 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The MRQ is 0.945. The company is less efficient in keeping operating costs low.
  • The TTM is 0.923. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.945TTM0.923+0.022
TTM0.923YOY1.027-0.104
TTM0.9235Y0.964-0.041
5Y0.96410Y0.9640.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9451.324-0.379
TTM0.9231.340-0.417
YOY1.0271.329-0.302
5Y0.9641.373-0.409
10Y0.9641.321-0.357
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Medprin Regenerative Medical Technologies Co. Ltd..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Medprin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 6.54 means the company has ¥6.54 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The MRQ is 6.538. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.092. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.538TTM5.092+1.446
TTM5.092YOY4.689+0.403
TTM5.0925Y6.171-1.079
5Y6.17110Y6.1710.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5382.573+3.965
TTM5.0922.666+2.426
YOY4.6892.922+1.767
5Y6.1713.393+2.778
10Y6.1713.470+2.701
4.4.3.2. Quick Ratio

Measures if Medprin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medprin to the Medical Devices industry mean.
  • A Quick Ratio of 3.64 means the company can pay off ¥3.64 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The MRQ is 3.636. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.378. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.636TTM3.378+0.258
TTM3.378YOY3.703-0.325
TTM3.3785Y4.776-1.399
5Y4.77610Y4.7760.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6361.557+2.079
TTM3.3781.698+1.680
YOY3.7031.896+1.807
5Y4.7762.296+2.480
10Y4.7762.545+2.231
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Medprin Regenerative Medical Technologies Co. Ltd..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Medprin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medprin to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.10 means that Medprin assets are financed with 10.2% credit (debt) and the remaining percentage (100% - 10.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The MRQ is 0.102. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.163. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.102TTM0.163-0.061
TTM0.163YOY0.184-0.021
TTM0.1635Y0.180-0.016
5Y0.18010Y0.1800.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1020.407-0.305
TTM0.1630.398-0.235
YOY0.1840.360-0.176
5Y0.1800.437-0.257
10Y0.1800.459-0.279
4.5.4.2. Debt to Equity Ratio

Measures if Medprin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medprin to the Medical Devices industry mean.
  • A Debt to Equity ratio of 11.3% means that company has ¥0.11 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The MRQ is 0.113. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.197. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.113TTM0.197-0.084
TTM0.197YOY0.227-0.030
TTM0.1975Y0.221-0.024
5Y0.22110Y0.2210.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1130.556-0.443
TTM0.1970.589-0.392
YOY0.2270.525-0.298
5Y0.2210.630-0.409
10Y0.2210.698-0.477
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Medprin generates.

  • Above 15 is considered overpriced but always compare Medprin to the Medical Devices industry mean.
  • A PE ratio of 37.28 means the investor is paying ¥37.28 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The EOD is 46.479. Based on the earnings, the company is overpriced. -1
  • The MRQ is 37.281. Based on the earnings, the company is overpriced. -1
  • The TTM is 42.050. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD46.479MRQ37.281+9.199
MRQ37.281TTM42.050-4.769
TTM42.050YOY117.506-75.457
TTM42.0505Y74.943-32.893
5Y74.94310Y74.9430.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD46.479-1.057+47.536
MRQ37.281-1.333+38.614
TTM42.050-2.000+44.050
YOY117.506-2.324+119.830
5Y74.943-2.124+77.067
10Y74.943-2.203+77.146
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The EOD is 125.544. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 100.698. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 65.233. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD125.544MRQ100.698+24.846
MRQ100.698TTM65.233+35.465
TTM65.233YOY22.078+43.154
TTM65.2335Y29.105+36.128
5Y29.10510Y29.1050.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD125.544-1.358+126.902
MRQ100.698-1.767+102.465
TTM65.233-2.161+67.394
YOY22.078-5.503+27.581
5Y29.105-3.904+33.009
10Y29.105-4.711+33.816
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Medprin is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 4.08 means the investor is paying ¥4.08 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Medprin Regenerative Medical Technologies Co. Ltd.:

  • The EOD is 5.088. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.081. Based on the equity, the company is fair priced.
  • The TTM is 4.053. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.088MRQ4.081+1.007
MRQ4.081TTM4.053+0.027
TTM4.053YOY4.797-0.743
TTM4.0535Y4.496-0.443
5Y4.49610Y4.4960.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD5.0882.101+2.987
MRQ4.0812.141+1.940
TTM4.0532.339+1.714
YOY4.7973.045+1.752
5Y4.4964.091+0.405
10Y4.4964.612-0.116
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets709,810
Total Liabilities72,314
Total Stockholder Equity637,496
 As reported
Total Liabilities 72,314
Total Stockholder Equity+ 637,496
Total Assets = 709,810

Assets

Total Assets709,810
Total Current Assets227,576
Long-term Assets482,234
Total Current Assets
Cash And Cash Equivalents 32,034
Short-term Investments 112,660
Net Receivables 13,895
Inventory 33,720
Other Current Assets 30,260
Total Current Assets  (as reported)227,576
Total Current Assets  (calculated)222,570
+/- 5,006
Long-term Assets
Property Plant Equipment 314,872
Intangible Assets 91,827
Long-term Assets Other 26,289
Long-term Assets  (as reported)482,234
Long-term Assets  (calculated)432,988
+/- 49,247

Liabilities & Shareholders' Equity

Total Current Liabilities34,808
Long-term Liabilities37,507
Total Stockholder Equity637,496
Total Current Liabilities
Accounts payable 10,186
Other Current Liabilities 4,765
Total Current Liabilities  (as reported)34,808
Total Current Liabilities  (calculated)14,951
+/- 19,857
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt300
Long-term Liabilities  (as reported)37,507
Long-term Liabilities  (calculated)300
+/- 37,207
Total Stockholder Equity
Retained Earnings 120,122
Total Stockholder Equity (as reported)637,496
Total Stockholder Equity (calculated)120,122
+/- 517,374
Other
Capital Stock66,063
Common Stock Shares Outstanding 66,063
Net Invested Capital 637,496
Net Working Capital 192,768
Property Plant and Equipment Gross 314,872



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
> Total Assets 
725,056
752,305
767,746
0
728,447
720,160
756,419
786,969
778,037
709,810
709,810778,037786,969756,419720,160728,4470767,746752,305725,056
   > Total Current Assets 
374,706
346,607
297,559
0
221,471
212,695
238,061
269,712
265,899
227,576
227,576265,899269,712238,061212,695221,4710297,559346,607374,706
       Cash And Cash Equivalents 
8,351
37,760
28,553
0
12,838
14,559
38,845
26,677
49,381
32,034
32,03449,38126,67738,84514,55912,838028,55337,7608,351
       Short-term Investments 
333,720
265,679
233,722
0
166,383
160,520
155,822
192,819
166,797
112,660
112,660166,797192,819155,822160,520166,3830233,722265,679333,720
       Net Receivables 
4,998
13,500
7,000
0
6,428
4,766
9,783
18,077
14,074
13,895
13,89514,07418,0779,7834,7666,42807,00013,5004,998
       Inventory 
21,036
23,839
22,507
0
28,806
26,200
27,926
26,198
30,344
33,720
33,72030,34426,19827,92626,20028,806022,50723,83921,036
       Other Current Assets 
567
173
821
0
118
255
43
70
31
30,260
30,2603170432551180821173567
   > Long-term Assets 
350,350
405,697
470,187
0
506,977
507,466
518,358
517,257
512,138
482,234
482,234512,138517,257518,358507,466506,9770470,187405,697350,350
       Property Plant Equipment 
0
0
0
0
317,171
313,887
320,455
319,155
315,936
314,872
314,872315,936319,155320,455313,887317,1710000
       Intangible Assets 
76,910
80,049
82,258
0
87,613
93,145
94,481
94,235
92,856
91,827
91,82792,85694,23594,48193,14587,613082,25880,04976,910
       Long-term Assets Other 
16,996
39,011
57,713
0
56,019
54,405
55,172
55,224
55,256
26,289
26,28955,25655,22455,17254,40556,019057,71339,01116,996
> Total Liabilities 
142,246
162,174
172,186
0
118,049
118,899
141,625
151,111
133,480
72,314
72,314133,480151,111141,625118,899118,0490172,186162,174142,246
   > Total Current Liabilities 
26,923
48,238
58,976
0
46,719
49,674
55,885
68,124
47,395
34,808
34,80847,39568,12455,88549,67446,719058,97648,23826,923
       Accounts payable 
13,762
30,414
44,722
0
29,330
26,691
29,510
31,930
19,392
10,186
10,18619,39231,93029,51026,69129,330044,72230,41413,762
       Other Current Liabilities 
625
769
713
0
851
1,121
912
809
1,551
4,765
4,7651,5518099121,1218510713769625
   > Long-term Liabilities 
115,324
113,936
113,210
0
71,329
69,226
85,740
82,987
86,085
37,507
37,50786,08582,98785,74069,22671,3290113,210113,936115,324
       Long term Debt 
101,674
101,662
101,662
0
50,299
49,010
49,010
46,430
46,430
0
046,43046,43049,01049,01050,2990101,662101,662101,674
       Capital Lease Obligations Min Short Term Debt
6,002
5,375
3,387
0
2,356
1,914
1,467
1,014
556
300
3005561,0141,4671,9142,35603,3875,3756,002
> Total Stockholder Equity
579,208
586,677
595,560
0
610,399
601,261
614,794
635,858
644,557
637,496
637,496644,557635,858614,794601,261610,3990595,560586,677579,208
   Common Stock0000000000
   Retained Earnings 
70,133
77,601
86,484
0
97,464
88,326
101,860
114,016
128,960
120,122
120,122128,960114,016101,86088,32697,464086,48477,60170,133
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 0000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue230,870
Cost of Revenue-41,543
Gross Profit189,327189,327
 
Operating Income (+$)
Gross Profit189,327
Operating Expense-185,692
Operating Income45,1783,635
 
Operating Expense (+$)
Research Development26,779
Selling General Administrative76,405
Selling And Marketing Expenses0
Operating Expense185,692103,184
 
Net Interest Income (+$)
Interest Income1,884
Interest Expense-2,029
Other Finance Cost-199
Net Interest Income-344
 
Pretax Income (+$)
Operating Income45,178
Net Interest Income-344
Other Non-Operating Income Expenses0
Income Before Tax (EBT)48,02245,178
EBIT - interestExpense = -2,029
40,877
42,907
Interest Expense2,029
Earnings Before Interest and Taxes (EBIT)050,051
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax48,022
Tax Provision-7,144
Net Income From Continuing Ops40,87740,877
Net Income40,877
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0344
 

Technical Analysis of Medprin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medprin. The general trend of Medprin is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medprin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Medprin Regenerative Medical Technologies Co. Ltd..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 54.95 < 57.32.

The bearish price targets are: 43.43 > 43.37 > 43.00.

Tweet this
Medprin Regenerative Medical Technologies Co. Ltd. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Medprin Regenerative Medical Technologies Co. Ltd.. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Medprin Regenerative Medical Technologies Co. Ltd. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Medprin Regenerative Medical Technologies Co. Ltd.. The current macd is 0.83778563.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medprin price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Medprin. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Medprin price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Medprin Regenerative Medical Technologies Co. Ltd. Daily Moving Average Convergence/Divergence (MACD) ChartMedprin Regenerative Medical Technologies Co. Ltd. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Medprin Regenerative Medical Technologies Co. Ltd.. The current adx is 29.83.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Medprin shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Medprin Regenerative Medical Technologies Co. Ltd. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Medprin Regenerative Medical Technologies Co. Ltd.. The current sar is 46.38.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Medprin Regenerative Medical Technologies Co. Ltd. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Medprin Regenerative Medical Technologies Co. Ltd.. The current rsi is 51.88. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Medprin Regenerative Medical Technologies Co. Ltd. Daily Relative Strength Index (RSI) ChartMedprin Regenerative Medical Technologies Co. Ltd. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Medprin Regenerative Medical Technologies Co. Ltd.. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Medprin price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Medprin Regenerative Medical Technologies Co. Ltd. Daily Stochastic Oscillator ChartMedprin Regenerative Medical Technologies Co. Ltd. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Medprin Regenerative Medical Technologies Co. Ltd.. The current cci is -33.06869215.

Medprin Regenerative Medical Technologies Co. Ltd. Daily Commodity Channel Index (CCI) ChartMedprin Regenerative Medical Technologies Co. Ltd. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Medprin Regenerative Medical Technologies Co. Ltd.. The current cmo is -2.48027636.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Medprin Regenerative Medical Technologies Co. Ltd. Daily Chande Momentum Oscillator (CMO) ChartMedprin Regenerative Medical Technologies Co. Ltd. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Medprin Regenerative Medical Technologies Co. Ltd.. The current willr is -70.74285714.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Medprin is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Medprin Regenerative Medical Technologies Co. Ltd. Daily Williams %R ChartMedprin Regenerative Medical Technologies Co. Ltd. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Medprin Regenerative Medical Technologies Co. Ltd..

Medprin Regenerative Medical Technologies Co. Ltd. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Medprin Regenerative Medical Technologies Co. Ltd.. The current atr is 2.42438655.

Medprin Regenerative Medical Technologies Co. Ltd. Daily Average True Range (ATR) ChartMedprin Regenerative Medical Technologies Co. Ltd. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Medprin Regenerative Medical Technologies Co. Ltd.. The current obv is 19,097,627.

Medprin Regenerative Medical Technologies Co. Ltd. Daily On-Balance Volume (OBV) ChartMedprin Regenerative Medical Technologies Co. Ltd. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Medprin Regenerative Medical Technologies Co. Ltd.. The current mfi is 58.15.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Medprin Regenerative Medical Technologies Co. Ltd. Daily Money Flow Index (MFI) ChartMedprin Regenerative Medical Technologies Co. Ltd. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Medprin Regenerative Medical Technologies Co. Ltd..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Medprin Regenerative Medical Technologies Co. Ltd. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Medprin Regenerative Medical Technologies Co. Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.883
Ma 20Greater thanMa 5049.700
Ma 50Greater thanMa 10045.418
Ma 100Greater thanMa 20042.359
OpenGreater thanClose48.990
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Medprin with someone you think should read this too:
  • Are you bullish or bearish on Medprin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medprin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Medprin Regenerative Medical Technologies Co. Ltd.

I send you an email if I find something interesting about Medprin Regenerative Medical Technologies Co. Ltd..


Comments

How you think about this?

Leave a comment

Stay informed about Medprin Regenerative Medical Technologies Co. Ltd..

Receive notifications about Medprin Regenerative Medical Technologies Co. Ltd. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.